286 related articles for article (PubMed ID: 32693030)
1. Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future.
Boutary S; Echaniz-Laguna A; Adams D; Loisel-Duwattez J; Schumacher M; Massaad C; Massaad-Massade L
Transl Res; 2021 Jan; 227():100-111. PubMed ID: 32693030
[TBL] [Abstract][Full Text] [Related]
2. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
3. [Detection of the PMP22 gene duplication in peripheral neuropathy patients: a study in Mexican population].
Cortés H; Hernández-Hernández Ó; Bautista-Tirado T; Escobar-Cedillo RE; Magaña JJ; Leyva-García N
Rev Neurol; 2014 Aug; 59(3):111-7. PubMed ID: 25030070
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
[TBL] [Abstract][Full Text] [Related]
5. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
6. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
7. Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication.
Kim SM; Lee J; Yoon BR; Kim YJ; Choi BO; Chung KW
J Hum Genet; 2015 Feb; 60(2):103-6. PubMed ID: 25500726
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
9. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical features of inherited neuropathies due to PMP22 duplication.
Watila MM; Balarabe SA
J Neurol Sci; 2015 Aug; 355(1-2):18-24. PubMed ID: 26076881
[TBL] [Abstract][Full Text] [Related]
11. Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome.
King PH; Waldrop R; Lupski JR; Shaffer LG
Clin Genet; 1998 Nov; 54(5):413-6. PubMed ID: 9842994
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
[TBL] [Abstract][Full Text] [Related]
13. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
14. Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication.
Liu X; Ishikawa KI; Hattori N; Akamatsu W
Stem Cell Res; 2024 Jun; 77():103401. PubMed ID: 38537501
[TBL] [Abstract][Full Text] [Related]
15. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
Roa BB; Garcia CA; Lupski JR
Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of Charcot-Marie-Tooth disease type 1A: gene dosage as a novel mechanism for a common autosomal dominant condition.
Roa BB; Lupski JR
Am J Med Sci; 1993 Sep; 306(3):177-84. PubMed ID: 8128981
[TBL] [Abstract][Full Text] [Related]
18. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies.
Aarskog NK; Vedeler CA
Hum Genet; 2000 Nov; 107(5):494-8. PubMed ID: 11140948
[TBL] [Abstract][Full Text] [Related]
19. [PMP22 mutation of an infant-onset Charcot-Marie-Tooth disease family].
Xing JW; Liu YH; Shamsi BH; Liu XH; Tan L; Xu M
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Oct; 13(10):799-803. PubMed ID: 22000434
[TBL] [Abstract][Full Text] [Related]
20. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
